591 related articles for article (PubMed ID: 34013544)
1. Role of cancer-associated fibroblast subpopulations in immune infiltration, as a new means of treatment in cancer.
Mhaidly R; Mechta-Grigoriou F
Immunol Rev; 2021 Jul; 302(1):259-272. PubMed ID: 34013544
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast heterogeneity in tumor micro-environment: Role in immunosuppression and new therapies.
Mhaidly R; Mechta-Grigoriou F
Semin Immunol; 2020 Apr; 48():101417. PubMed ID: 33077325
[TBL] [Abstract][Full Text] [Related]
3. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
[TBL] [Abstract][Full Text] [Related]
4. Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.
Eskandari-Malayeri F; Rezaei M
Front Immunol; 2022; 13():996145. PubMed ID: 36275750
[TBL] [Abstract][Full Text] [Related]
5. From gatekeepers to providers: regulation of immune functions by cancer-associated fibroblasts.
Arpinati L; Scherz-Shouval R
Trends Cancer; 2023 May; 9(5):421-443. PubMed ID: 36870916
[TBL] [Abstract][Full Text] [Related]
6. The heterogeneity of cancer-associated fibroblast subpopulations: Their origins, biomarkers, and roles in the tumor microenvironment.
Yamamoto Y; Kasashima H; Fukui Y; Tsujio G; Yashiro M; Maeda K
Cancer Sci; 2023 Jan; 114(1):16-24. PubMed ID: 36197901
[TBL] [Abstract][Full Text] [Related]
7. Cancer-Associated Fibroblasts Suppress CD8+ T-cell Infiltration and Confer Resistance to Immune-Checkpoint Blockade.
Jenkins L; Jungwirth U; Avgustinova A; Iravani M; Mills A; Haider S; Harper J; Isacke CM
Cancer Res; 2022 Aug; 82(16):2904-2917. PubMed ID: 35749591
[TBL] [Abstract][Full Text] [Related]
8. Pan-cancer analyses and molecular subtypes based on the cancer-associated fibroblast landscape and tumor microenvironment infiltration characterization reveal clinical outcome and immunotherapy response in epithelial ovarian cancer.
Zou R; Jiang Q; Jin T; Chen M; Yao L; Ding H
Front Immunol; 2022; 13():956224. PubMed ID: 36032075
[TBL] [Abstract][Full Text] [Related]
9. Cancer-associated fibroblasts promote an immunosuppressive microenvironment through the induction and accumulation of protumoral macrophages.
Takahashi H; Sakakura K; Kudo T; Toyoda M; Kaira K; Oyama T; Chikamatsu K
Oncotarget; 2017 Jan; 8(5):8633-8647. PubMed ID: 28052009
[TBL] [Abstract][Full Text] [Related]
10. Interactions between cancer-associated fibroblasts and T-cells: functional crosstalk with targeting and biomarker potential.
Milosevic V; Östman A
Ups J Med Sci; 2024; 129():. PubMed ID: 38863724
[TBL] [Abstract][Full Text] [Related]
11. Cancer-associated fibroblast spatial heterogeneity and
Honda CK; Kurozumi S; Fujii T; Pourquier D; Khellaf L; Boissiere F; Horiguchi J; Oyama T; Shirabe K; Colinge J; Yokobori T; Turtoi A
Theranostics; 2024; 14(5):1873-1885. PubMed ID: 38505604
[No Abstract] [Full Text] [Related]
12. Cancer-Associated Fibroblasts in Conversation with Tumor Cells in Endometrial Cancers: A Partner in Crime.
Pradip D; Jennifer A; Nandini D
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502029
[TBL] [Abstract][Full Text] [Related]
13. Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials.
Zhang H; Yue X; Chen Z; Liu C; Wu W; Zhang N; Liu Z; Yang L; Jiang Q; Cheng Q; Luo P; Liu G
Mol Cancer; 2023 Oct; 22(1):159. PubMed ID: 37784082
[TBL] [Abstract][Full Text] [Related]
14. Cancer-associated fibroblasts: heterogeneity and their role in the tumor immune response.
Xiao Y; Wang Z; Gu M; Wei P; Wang X; Li W
Clin Exp Med; 2024 Jun; 24(1):126. PubMed ID: 38864912
[TBL] [Abstract][Full Text] [Related]
15. Single-cell and bulk RNA sequencing reveal cancer-associated fibroblast heterogeneity and a prognostic signature in prostate cancer.
Liu W; Wang M; Wang M; Liu M
Medicine (Baltimore); 2023 Aug; 102(32):e34611. PubMed ID: 37565899
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis in the Pancreatic Cancer Tumor Microenvironment-The Double-Edged Sword of Cancer-Associated Fibroblasts.
Pfeifer E; Burchell JM; Dazzi F; Sarker D; Beatson R
Cells; 2021 Jul; 10(7):. PubMed ID: 34359823
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of human prostate carcinoma-associated fibroblasts implicates a role for subpopulations in myeloid cell recruitment.
Vickman RE; Broman MM; Lanman NA; Franco OE; Sudyanti PAG; Ni Y; Ji Y; Helfand BT; Petkewicz J; Paterakos MC; Crawford SE; Ratliff TL; Hayward SW
Prostate; 2020 Feb; 80(2):173-185. PubMed ID: 31763714
[TBL] [Abstract][Full Text] [Related]
18. Cancer-Associated Fibroblast Subpopulations With Diverse and Dynamic Roles in the Tumor Microenvironment.
Simon T; Salhia B
Mol Cancer Res; 2022 Feb; 20(2):183-192. PubMed ID: 34670861
[TBL] [Abstract][Full Text] [Related]
19. Cancer-associated fibroblasts: Origin, function, imaging, and therapeutic targeting.
Rimal R; Desai P; Daware R; Hosseinnejad A; Prakash J; Lammers T; Singh S
Adv Drug Deliv Rev; 2022 Oct; 189():114504. PubMed ID: 35998825
[TBL] [Abstract][Full Text] [Related]
20. Cell Component and Function of Tumor Microenvironment in Thyroid Cancer.
Shin E; Koo JS
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]